血管紧张素转换酶抑制剂,angiotensin converting enzyme inhibitor
1)angiotensin converting enzyme inhibitor血管紧张素转换酶抑制剂
1.The purification and identification ofangiotensin converting enzyme inhibitor from Guangxi cobra venom;广西眼镜蛇毒中血管紧张素转换酶抑制剂的分离纯化及鉴定
2.Screening ofangiotensin converting enzyme inhibitors from Salvia miltiorrhizae;从丹参中筛选血管紧张素转换酶抑制剂
3.The influence of renal function on renoprotective effect ofangiotensin converting enzyme inhibitors (ACEI) in chronic glomerulonephritis patients;肾功能状态对3种血管紧张素转换酶抑制剂肾保护作用的影响
英文短句/例句
1.The Association between the Gene Polymorphism of Angiotensin Converting Enzyme (ACE)and ACE inhibitor-induced cough血管紧张素转换酶抑制剂所致咳嗽与血管紧张素转换酶基因多态性的关系
2.Inhibitory Effect of Angiotensin-converting Enzyme Inhibitor Combined with Nedaplatin on Human Nasopharyngeal Carcinoma CNE2 Cells血管紧张素转换酶抑制剂联合奈达铂对鼻咽癌CNE2细胞的抑制作用
3.Follow-up of the Effect on the Urokinase Combined with Angiotensin Converting Enzyme Inhibitor on IgA Nephropathy;尿激酶联合血管紧张素转换酶抑制剂治疗IgA肾病的随访观察
4.Relationship between Polymorphism of the Renin-angiotensin-aldosterone System (RAS) Gene and the Response to Angiotensin-converting Enzyme Inhibition in Hypertensive Patients;肾素—血管紧张素—醛固酮系统基因多态性与血管紧张素转换酶抑制剂疗效的相关性研究
5.Influence of Angiotensin-converting Enzyme Inhibitors on Myocardial Regeneration with Bone Marrow Cells Transplantation;血管紧张素转换酶抑制剂对骨髓干细胞心肌再生影响的实验研究
6.The clinical observation of treatment on the cough induced by angiotensin converting enzyme inhibitor血管紧张素转换酶抑制剂诱发咳嗽的临床治疗观察
7.Investigation on the Raw Materials Plant Resources of Angiotensin Converting Enzyme Inhibitor in Kunyu Mountain昆嵛山血管紧张素转换酶抑制剂原料植物资源调查
8.Clinical analysis of treatment with angiotension-converting-enzyme inhibitor and spironolactone in 25 cases with chronic congestive heart failure;血管紧张素转换酶抑制剂联用小剂量螺内酯治疗充血性心力衰竭25例临床分析
9.Advancements in Angiotensin Converting Enzyme Inhibitor Combined with Calcium Channel Blocker in Treatment of Hypertension血管紧张素转换酶抑制剂联合钙离子通道阻滞剂在高血压治疗中的应用进展
10.Effects of Angiotensin-converting Enzyme Inhibitors on Endothelial Function and the Number of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease;血管紧张素转换酶抑制剂对冠心病患者血管内皮功能及循环内皮祖细胞数量的影响
11.Effect of Angiotensin Converting Enzyme Inhibitors on Proliferation and Migration of Medial Smooth Muscle Cells of Rat Artery Injured by Balloon Chatheter;血管紧张素转换酶抑制剂对大鼠球囊导管损伤动脉中膜平滑肌细胞增生和迁移的影响
12.The Effect of Angiotensin-coverting Enzyme Inhibitor (Fsinopril Sodium) on Rabbit Abdominal Artery after Balloon-injury;血管紧张素转换酶抑制剂（福辛普利）对兔腹主动脉球囊损伤后的影响
13.Function analysis of ACEI with non-ST elevation acute coronary syndrome.血管紧张素转换酶抑制剂治疗非ST段抬高急性冠脉综合征临床观察
14.Research of Intervention of Angiotensin-Converting Enzyme Inhibitors to the Cytokines in the Patients with Heart Failure血管紧张素转换酶抑制剂对心力衰竭患者细胞因子干预作用的研究进展
15.② Purification of ACE inhibitory peptide;②血管紧张素转换酶抑制肽的纯化结果。
16.③ Amino acid analysis of ACE inhibitory peptides.③血管紧张素转换酶抑制肽的氨基酸分析。
17.Study on Synthesis of Trandolapril a Angiotensin-Converting Enzyme Inhibitor;血管紧张素转化酶抑制剂群多普利的合成研究
18.Kakkonein Depress the Angiogenesis Caused by Angiotensin-converting Enzyme 2(ACE2);葛根素抑制血管紧张素转换酶2（ACE2）的促血管生成作用
相关短句/例句
ACEI血管紧张素转换酶抑制剂
1.WhetherACEI should be used on low-risk patients with coronary artery disease-expounding on IMAGINE studies;低危冠心病患者是否应该使用血管紧张素转换酶抑制剂——IMAGINE研究解读
2.Effects ofACEI and Zhenju Jiangya tablet on ET, NO in type 2 diabetes;血管紧张素转换酶抑制剂及珍菊降压片对2型糖尿病内皮素、一氧化氮的影响
3.Investigate of angiotensin-converting enzyme inhibitors(ACEI) and vasopeptidas inhibitors(VPI);血管紧张素转换酶抑制剂和血管肽酶抑制剂研究进展
3)angiotensin-converting enzyme inhibitor血管紧张素转换酶抑制剂
1.Mechanism ofangiotensin-converting enzyme inhibitor in inhibiting intimal hypertrophy of injured rat artery;血管紧张素转换酶抑制剂抑制大鼠损伤动脉内膜肥厚的机制
2.Methods:Forty male Wistar rats were divided into four groups,Group A(n=10),B(n=10)medicine group,angiotensin-converting enzyme inhibitor(inhibace) 10 mg/kg/day was given orally to rats by gastric gavage in the morning once a day.25%百特透析液,同时血管紧张素转换酶抑制剂一平苏10 mg/kg。
3.Angiotensin-converting enzyme inhibitor/angiotensin Ⅱ receptor antagonist,which improves insulin sensitivity,decreases cardiovascular morbidity and the incidence of type 2 diabetes.血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体拮抗剂可通过改善胰岛素敏感性,使心血管疾病的发病率及新发2型糖尿病的发病率下降。
4)Angiotensin converting enzyme inhibitors血管紧张素转换酶抑制剂
1.Angiotensin converting enzyme inhibitors(ACEI)have been extensively applied to treat hypertension and diabetic nephropathy in the chronic renal failure patients.血管紧张素转换酶抑制剂(ACEI)已被广泛应用于治疗慢性肾衰竭患者的高血压以及糖尿病肾病等疾病,但是近年来研究报道关于ACEI是否影响促红细胞生成素(EPO)治疗慢性肾衰竭的疗效还存在争议,本文就其可能的机制以及一些临床研究作如下综述。
2.The data including primary kidney diseases and cardiovascular diseases of the patients and whether they took angiotensin converting enzyme inhibitors(ACELI)in the past three months were reviewed.调查患者原发病、心血管并发症及是否应用血管紧张素转换酶抑制剂(ACEI)治疗。
3.Objective: To study the prevalence of cough and withdrawal of angiotensin converting enzyme inhibitors (ACEI) in treatment of hypertension.目的:研究血管紧张素转换酶抑制剂(ACE抑制剂)治疗高血压的咳嗽发生率和停药率。
5)angiotensin-converting enzyme inhibitors血管紧张素转换酶抑制剂
1.Aim: To determine mechanisms of cardioprotection induced by combinationangiotensin-converting enzyme inhibitors(ACEI)with subthreshold preconditioning after activation of mitochondrial ATP-sensitive potassium(mitoK ATP )channel.目的探讨血管紧张素转换酶抑制剂(ACEI)和阈下缺血预处理联合预处理诱导的心肌保护作用中mi-toK_(ATP)通道激动后的作用机制。
2.The aim of the present study was to determine whetherangiotensin-converting enzyme inhibitors (ACEI) could contributeto the protective effects of preconditioning, and to explore its underlying mechanism.实验采用离体大鼠心脏Langendorff灌流模型,观察含巯基(卡托普利)和不含巯基(培哚普利拉)的两种血管紧张素转换酶抑制剂(angiotensin-convertingenzymeinhibitors,ACEI)对抗心肌缺血的作用,并探讨一氧化氮(nitricoxide,NO)和线粒体ATP敏感性钾通道(mitochondrialATP-sensitivepotassiumchannel,mitoKATPchannel)是否参与ACEI的心肌保护作用。
3.Objective To investigate the effect ofangiotensin-converting enzyme inhibitors on incidence of aspiratory pneumonia in elderly hypertensive stroke patients with chronic obstructive pulmonary disease.目的观察合并高血压的脑卒中并发稳定期慢性阻塞性肺疾病患者应用血管紧张素转换酶抑制剂(ACEI)类降压药对其预防吸入性肺炎的影响。
6)renin angiotensin converting enzyme inhibitor肾素血管紧张素转换酶抑制剂(RACI)
延伸阅读
血管紧张素转换酶抑制剂血管紧张素转换酶抑制剂converting enzyme inhibitor of angiotensin能够抑制血管紧张素转换酶的活性、使血管紧张素Ⅰ不能转换成血管紧张素Ⅱ的物质，如替普罗肽(又称SQ20881）及卡托普利(又称SQ14225）。用于肾血管性高血压及高血压危象。
